(Q33992704)

30 July 2017

1 reference

title

The clinical usefulness of the measurement of cytokines (English)

1 reference

30 July 2017

J Bienvenu

1

1 reference

30 July 2017

G Monneret

series ordinal

2

1 reference

30 July 2017

N Fabien

series ordinal

3

1 reference

30 July 2017

J P Revillard

series ordinal

4

1 reference

30 July 2017

publication date

1 April 2000

1 reference

Clinical Chemistry and Laboratory Medicine

30 July 2017

published in

1 reference

30 July 2017

volume

38

1 reference

30 July 2017

issue

4

1 reference

30 July 2017

page(s)

267-285

1 reference

Determination of IL1 alpha, IL1 beta and IL2 in biological media using specific enzyme immunometric assays

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

High-affinity IgG autoantibodies to IL-6 in sera of normal individuals are competitive inhibitors of IL-6 in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Circadian rhythm of serum interleukin-6 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Detection and measurement of cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Evaluation of an automated immunoassay method for cytokine measurement using the Immulite Immunoassay system.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Variable estimates of cytokine levels produced by commercial ELISA kits: results using international cytokine standards

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Cytokine measurements and interpretation of cytokine assays in human disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Detection of human cytokine-secreting cells in distinct anatomical compartments

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Individual cells simultaneously produce both IL-4 and IL-6 in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Measurement of intracellular cytokines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Assessment of cytokines by immunofluorescence and the paraformaldehyde-saponin procedure

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Detection of intracytoplasmic cytokine using flow cytometry and directly conjugated anti-cytokine antibodies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Sequential production of IL-2, IFN-gamma and IL-10 by individual staphylococcal enterotoxin B-activated T helper lymphocytes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Selective expression of an interleukin-12 receptor component by human T helper 1 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

The chemokine receptors CXCR3 and CCR5 mark subsets of T cells associated with certain inflammatory reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Chemokines and T lymphocytes: more than an attraction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Selective expression of a stable cell surface molecule on type 2 but not type 1 helper T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

T1/ST2 is preferentially expressed on murine Th2 cells, independent of interleukin 4, interleukin 5, and interleukin 10, and important for Th2 effector function

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Analysis of cytokine mRNA and DNA: detection and quantitation by competitive polymerase chain reaction

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

A synthetic standard DNA construct for use in quantification of murine cytokine mRNA molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

HMG-1 as a late mediator of endotoxin lethality in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Amniotic fluid interleukin 6 in preterm labor. Association with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Sepsis: a new hypothesis for pathogenesis of the disease process

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Tumour necrosis factor-alpha and interleukin-10 production in septic patients and the regulatory effect of plasma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

An endotoxin-induced serum factor that causes necrosis of tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Death receptors: signaling and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Interleukin-12: a proinflammatory cytokine with immunoregulatory functions that bridge innate resistance and antigen-specific adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Serum levels of interleukin 6, a potent myeloma cell growth factor, as a reflect of disease severity in plasma cell dyscrasias

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Tumour necrosis factor-alpha, interleukin-1 beta and interleukin-6 in patients with renal cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Serum interleukin 6 and C-reactive protein levels correlate with resistance to IL-2 therapy and poor survival in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Circulating levels of colony-stimulating factor 1 as a prognostic indicator in 82 patients with epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Occurrence of TEL-AML1 fusion resulting from (12;21) translocation in human early B-lineage leukemia cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Lymphokine production by human T cells in disease states

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Immunoregulatory role of interleukin 10 in rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Role of interleukin 10 in the B lymphocyte hyperactivity and autoantibody production of human systemic lupus erythematosus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

CD40 and IgE: synergism between anti-CD40 monoclonal antibody and interleukin 4 in the induction of IgE synthesis by highly purified human B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

CD21 is a ligand for CD23 and regulates IgE production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Allergen- and bacterial antigen-specific T-cell clones established from atopic donors show a different profile of cytokine production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Development of allergen-specific T-cell memory in atopic and normal children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

In vitro correlates of the acute toxic syndrome induced by some monoclonal antibodies: a rationale for the design of predictive tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Mechanism of first-dose cytokine-release syndrome by CAMPATH 1-H: involvement of CD16 (FcgammaRIII) and CD11a/CD18 (LFA-1) on NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Polymorphic structure of the tumor necrosis factor (TNF) locus: an NcoI polymorphism in the first intron of the human TNF-beta gene correlates with a variant amino acid in position 26 and a reduced level of TNF-beta production

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Association of tumor necrosis factor (TNF) and class II major histocompatibility complex alleles with the secretion of TNF-a and TNF-0 by human mononuclear cells: a possible link to insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Variation in the TNF-alpha promoter region associated with susceptibility to cerebral malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Tumor necrosis factor promoter polymorphism and susceptibility to lepromatous leprosy

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Germline mutations in the extracellular domains of the 55 kDa TNF receptor, TNFR1, define a family of dominantly inherited autoinflammatory syndromes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

IL-10 Gene Promoter Polymorphisms in Rheumatoid Arthritis: SHORT REPORT

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

CCR5 is characteristic of Th1 lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

Autocrine generation and requirement of BSF-2/IL-6 for human multiple myelomas

21 January 2018

1 reference

https://api.crossref.org/works/10.1515%2FCCLM.2000.040

21 January 2018

Identifiers

DOI

10.1515/CCLM.2000.040

1 reference

30 July 2017

1 reference